News
Moving on, Regeneron’s second-quarter report was largely positive. Total revenues of $3.68 billion (up 4% YoY) beat analyst ...
Stocktwits on MSN6h
This Stock Has Tumbled 50% In One Year, Gets A Price Target Cut Today – But Retail Believes $400-450 Is A Good Entry Point
Truist on Monday lowered its price target on Regeneron (REGN) to $812 from $940, citing concerns with the company’s Eylea ...
Zevra, Inovio and Journey Medical are set for potential earnings beat this week, backed by strong products and positive ESP ...
Regeneron Court Permits Government to Pursue False Certification Theory - On August 4, the district court in the closely ...
Second-Quarter 2025 and Recent Selected Highlights: <li /> Total revenues of $63.7 million, a 30% increase over $48.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback